Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02182622
Title LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel
Recruitment Withdrawn
Gender male
Phase Phase I
Variant Requirements No
Sponsors Martin Gutierrez
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
John Theurer Cancer @ HackensackUMC Hackensack New Jersey 07601 United States Details
*Shaded cells indicate that there was no data available from for the field